bevacizumab
roche
['ovarian', 'gyn', 'beva', 'bevacizumab', 'improve ']
oral abstracts #asco22 #gyncsm seki bevacizumab in first-line chemotherapy to improve the survival outcome for advanced ovarian clear cell carcinoma
bev approved 2013 in japan
bev benefit for ccc 
#ovca survivor; research advocate; author; co-moderator #gyncsm chat;  #ASCO22 Feature Voice  COI: https://t.co/AUF1EprNVt Opinions are my own.